CD86 and neoplasm: Grouping all vaccinated mice together, the percentage of CD86+ and CD206+ tumor-associated macrophages (TAMs) was significantly lower in the vaccinated groups compared to that of the PBS control group (p = 0.0124 and p = 0.046, respectively).